Authors:
ASSELAH T
BERNUAU J
MARTINOTPEIGNOUX M
DURAND F
PHARM BN
LEBRETON V
BENHAMOU JP
ERLINGER S
VALLA D
MARCELLIN P
Citation: T. Asselah et al., LACK OF EVIDENCE OF HEPATITIS-C VIRUS-INFECTION IN PATIENTS WITH SEVERE ACUTE HEPATITIS-A, Hepatology, 28(4), 1998, pp. 819-819
Authors:
CHOW WC
BOYER N
POUTEAU M
CASTELNAU C
MARTINOTPEIGNOUX M
MARTINSAMADO V
DEGOS F
MAGHINICI C
SINEGRE M
BENHAMOU JP
DEGOTT C
ERLINGER S
MARCELLIN P
Citation: Wc. Chow et al., RETREATMENT WITH INTERFERON-ALPHA OF PATIENTS WITH CHRONIC HEPATITIS-C, Hepatology, 27(4), 1998, pp. 1144-1148
Authors:
MARTINOTPEIGNOUX M
BOYER N
POUTEAU M
CASTELNAU C
GIUILY N
DUCHATELLE V
AUPERIN A
DEGOTT C
BENHAMOU JP
ERLINGER S
MARCELLIN P
Citation: M. Martinotpeignoux et al., PREDICTORS OF SUSTAINED RESPONSE TO ALPHA-INTERFERON THERAPY IN CHRONIC HEPATITIS-C, Journal of hepatology, 29(2), 1998, pp. 214-223
Authors:
THEVENOT T
DIMARTINO V
COLIN JF
DEGOS F
ERLINGER S
BENHAMOU JP
MARCELLIN P
Citation: T. Thevenot et al., DETRIMENTAL INFLUENCE OF HIV ON THE NATURAL-HISTORY AND THE INTERFERON (IFN) RESPONSE RATE IN PATIENTS WITH CHRONIC HEPATITIS-B (CHB), Gastroenterology, 114(4), 1998, pp. 640-640
Authors:
MARCELLIN P
GIUILY N
LORIOT MA
DURAND F
SAMUEL D
BETTAN L
DEGOTT C
BERNUAU J
BENHAMOU JP
ERLINGER S
Citation: P. Marcellin et al., PROLONGED INTERFERON-ALPHA THERAPY OF HEPATITIS-B VIRUS-RELATED DECOMPENSATED CIRRHOSIS, Journal of viral hepatitis, 4, 1997, pp. 21-26
Authors:
LEVY S
VIARD JP
VALLA DC
DEGOTT C
BENHAMOU JP
ERLINGER S
Citation: S. Levy et al., ARE ANTI-BETA-2-GLYCOPROTEIN-I (ABGP-I) AND ANTICARDIOLIPIN (ACL) ANTIBODIES MARKERS OF AUTOIMMUNE LIVER-DISEASE, Hepatology, 26(4), 1997, pp. 1681-1681
Authors:
LORIOT MA
MARCELLIN P
WALKER F
BOYER N
DEGOTT C
RANDRIANATOAVINA I
BENHAMOU JP
ERLINGER S
Citation: Ma. Loriot et al., PERSISTENCE OF HEPATITIS-B VIRUS-DNA IN SERUM AND LIVER FROM PATIENTSWITH CHRONIC HEPATITIS-B AFTER LOSS OF HBSAG, Journal of hepatology, 27(2), 1997, pp. 251-258
Authors:
DURAND F
DEGOTT C
SAUVANET A
MOLAS G
SICOT C
MARCELLIN P
BELGHITI J
ERLINGER S
BENHAMOU JP
BERNUAU J
Citation: F. Durand et al., SUBFULMINANT SYNCYTIAL GIANT-CELL HEPATITIS - RECURRENCE AFTER LIVER-TRANSPLANTATION TREATED WITH RIBAVIRIN, Journal of hepatology, 26(3), 1997, pp. 722-726
Authors:
MARCELLIN P
BOYER N
GERVAIS A
MARTINOT M
POUTEAU M
CASTELNAU C
KILANI A
AREIAS J
AUPERIN A
BENHAMOU JP
DEGOTT C
ERLINGER S
Citation: P. Marcellin et al., LONG-TERM HISTOLOGIC IMPROVEMENT AND LOSS OF DETECTABLE INTRAHEPATIC HCV RNA IN PATIENTS WITH CHRONIC HEPATITIS-C AND SUSTAINED RESPONSE TOINTERFERON-ALPHA THERAPY, Annals of internal medicine, 127(10), 1997, pp. 875
Authors:
MARTINOT M
MARCELLIN P
BOYER N
DETMER J
POUTEAU M
CASTELNAU C
DEGOTT C
AUPERIN A
COLLINS M
KOLBERG J
WILBER J
BENHAMOU JP
ERLINGER S
Citation: M. Martinot et al., INFLUENCE OF HEPATITIS-G VIRUS-INFECTION ON THE SEVERITY OF LIVER-DISEASE AND RESPONSE TO INTERFERON-ALPHA IN PATIENTS WITH CHRONIC HEPATITIS-C, Annals of internal medicine, 126(11), 1997, pp. 874
Authors:
MOSNIER JF
FLEJOU JF
DEGOS F
BELGHITI J
BROUET JC
BENHAMOU JP
DEGOTT C
Citation: Jf. Mosnier et al., PLASMA-CELL VARIANT OF CASTLEMANS DISEASE LOCALIZED TO THE LIVER - A CASE-REPORT, European journal of gastroenterology & hepatology, 8(2), 1996, pp. 169-172
Authors:
LEVY S
MARCELLIN P
MARTINOTPEIGNOUX M
DEGOTT C
MARTINSAMADO V
BENHAMOU JP
ERLINGER S
Citation: S. Levy et al., HCV GENOTYPES AND HISTOLOGICAL LESIONS IN HCV CHRONIC CARRIERS WITH PERSISTENTLY NORMAL AMINOTRANSFERASES, Hepatology, 24(4), 1996, pp. 101-101
Authors:
MARTINOT M
MARCELLIN P
POUTEAU M
CASTELNAU C
BOYER N
RANDRIANATOAVINA I
LEBRETON V
BENHAMOU JP
ERLINGER S
Citation: M. Martinot et al., PREDICTORS OF RESPONSE TO ALPHA-INTERFERON THERAPY IN CHRONIC HEPATITIS-C - A MULTIVARIATE-ANALYSIS IN 287 PATIENTS, Hepatology, 23(1), 1996, pp. 44-44
Authors:
BOYER N
MARCELLIN P
DUCHATELLE V
MARTINOT M
KILANI A
POUTEAU M
DESCOMBES I
BENHAMOU JP
DEGOTT C
ERLINGER S
Citation: N. Boyer et al., SUSTAINED RESPONSE AFTER ALPHA-INTERFERON THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C, Hepatology, 23(1), 1996, pp. 101-101
Authors:
MARCELLIN P
KILANI A
MARTINOT M
GOURNAY J
CYMES K
BENHAMOU JP
DEGOTT C
ERLINGER S
Citation: P. Marcellin et al., VIROLOGICAL AND HISTOLOGICAL CHARACTERISTICS IN ANTI-HCV POSITIVE SUBJECTS WITH NORMAL TRANSAMINASES LEVELS, Hepatology, 23(1), 1996, pp. 165-165
Authors:
MARCELLIN P
MARTINOT M
KILANI A
DUCHATELLE V
GOURNAY J
RANDRIANATOAVINA I
LEBRETON V
DEGOTT C
BENHAMOU JP
ERLINGER S
Citation: P. Marcellin et al., RELATIONSHIP BETWEEN THE SEVERITY OF THE LIVER-DISEASE AND EPIDEMIOLOGIC AND VIROLOGICAL FEATURES IN PATIENTS WITH CHRONIC HCV INFECTION, Hepatology, 23(1), 1996, pp. 166-166
Authors:
KROGSGAARD K
MARCELLIN P
TREPO C
BERTHELOT P
SANCHEZTAPIAS JM
BASSENDINE M
TRAN A
OUZAN D
RINGLARSEN H
LINDBERG J
ENRIQUEZ J
BENHAMOU JP
BINDSLEV N
BERTET S
BOYER N
BRIND A
CIVEIRA MP
HOUSSET C
LUNDLAURSEN A
MAS A
POL S
PRIETO J
QUEDENS J
RAMPAL P
SCHLICHTING P
SORIANO G
SPACEY BEM
HAWLEY S
BRAND C
HOWE I
Citation: K. Krogsgaard et al., PREDNISOLONE WITHDRAWAL THERAPY ENHANCES THE EFFECT OF HUMAN LYMPHOBLASTOID INTERFERON IN CHRONIC HEPATITIS-B, Journal of hepatology, 25(6), 1996, pp. 803-813